Literature DB >> 20639485

Comparison of OX40 ligand and CD70 in the promotion of CD4+ T cell responses.

Jonathan S Kurche1, Matthew A Burchill, Phillip J Sanchez, Catherine Haluszczak, Ross M Kedl.   

Abstract

The TNF superfamily members CD70 and OX40 ligand (OX40L) were reported to be important for CD4(+) T cell expansion and differentiation. However, the relative contribution of these costimulatory signals in driving CD4(+) T cell responses has not been addressed. In this study, we found that OX40L is a more important determinant than CD70 of the primary CD4(+) T cell response to multiple immunization regimens. Despite the ability of a combined TLR and CD40 agonist (TLR/CD40) stimulus to provoke appreciable expression of CD70 and OX40L on CD8(+) dendritic cells, resulting CD4(+) T cell responses were substantially reduced by Ab blockade of OX40L and, to a lesser degree, CD70. In contrast, the CD8(+) T cell responses to combined TLR/CD40 immunization were exclusively dependent on CD70. These requirements for CD4(+) and CD8(+) T cell activation were not limited to the use of combined TLR/CD40 immunization, because vaccinia virus challenge elicited primarily OX40L-dependent CD4 responses and exclusively CD70-dependent CD8(+) T cell responses. Attenuation of CD4(+) T cell priming induced by OX40L blockade was independent of signaling through the IL-12R, but it was reduced further by coblockade of CD70. Thus, costimulation by CD70 or OX40L seems to be necessary for primary CD4(+) T cell responses to multiple forms of immunization, and each may make independent contributions to CD4(+) T cell priming.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20639485      PMCID: PMC3863553          DOI: 10.4049/jimmunol.1000172

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  58 in total

1.  Epidermal viral immunity induced by CD8alpha+ dendritic cells but not by Langerhans cells.

Authors:  Rhys S Allan; Chris M Smith; Gabrielle T Belz; Allison L van Lint; Linda M Wakim; William R Heath; Francis R Carbone
Journal:  Science       Date:  2003-09-26       Impact factor: 47.728

2.  Stimulation by soluble CD70 promotes strong primary and secondary CD8+ cytotoxic T cell responses in vivo.

Authors:  Tania F Rowley; Aymen Al-Shamkhani
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

Review 3.  Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know.

Authors:  Giuseppe Pantaleo; Richard A Koup
Journal:  Nat Med       Date:  2004-08       Impact factor: 53.440

4.  A role for CD40 expression on CD8+ T cells in the generation of CD8+ T cell memory.

Authors:  Christine Bourgeois; Benedita Rocha; Corinne Tanchot
Journal:  Science       Date:  2002-09-20       Impact factor: 47.728

5.  Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes.

Authors:  F Crawford; H Kozono; J White; P Marrack; J Kappler
Journal:  Immunity       Date:  1998-06       Impact factor: 31.745

6.  CD27-CD27 ligand/CD70 interactions enhance alloantigen-induced proliferation and cytolytic activity in CD8+ T lymphocytes.

Authors:  G R Brown; K Meek; Y Nishioka; D L Thiele
Journal:  J Immunol       Date:  1995-04-15       Impact factor: 5.422

7.  Lack of MHC class I complex expression has no effect on spread and control of cytomegalovirus infection in vivo.

Authors:  B Polić; S Jonjić; I Pavić; I Crnković; I Zorica; H Hengel; P Lucin; U H Koszinowski
Journal:  J Gen Virol       Date:  1996-02       Impact factor: 3.891

Review 8.  Pattern recognition receptors and control of adaptive immunity.

Authors:  Noah W Palm; Ruslan Medzhitov
Journal:  Immunol Rev       Date:  2009-01       Impact factor: 12.988

9.  Efficacious control of cytomegalovirus infection after long-term depletion of CD8+ T lymphocytes.

Authors:  S Jonjić; I Pavić; P Lucin; D Rukavina; U H Koszinowski
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

10.  Combined TLR and CD40 triggering induces potent CD8+ T cell expansion with variable dependence on type I IFN.

Authors:  Cory L Ahonen; Christie L Doxsee; Sean M McGurran; Tony R Riter; William F Wade; Richard J Barth; John P Vasilakos; Randolph J Noelle; Ross M Kedl
Journal:  J Exp Med       Date:  2004-03-08       Impact factor: 14.307

View more
  22 in total

1.  TLR7 enables cross-presentation by multiple dendritic cell subsets through a type I IFN-dependent pathway.

Authors:  Jason Z Oh; Jonathan S Kurche; Matthew A Burchill; Ross M Kedl
Journal:  Blood       Date:  2011-08-02       Impact factor: 22.113

2.  T cells compete by cleaving cell surface CD27 and blocking access to CD70-bearing APCs.

Authors:  Matthew A Burchill; Beth A Tamburini; Ross M Kedl
Journal:  Eur J Immunol       Date:  2015-08-03       Impact factor: 5.532

Review 3.  Stimulating CD27 to quantitatively and qualitatively shape adaptive immunity to cancer.

Authors:  Timothy Nj Bullock
Journal:  Curr Opin Immunol       Date:  2017-03-17       Impact factor: 7.486

4.  Generating a battery of monoclonal antibodies against native green fluorescent protein for immunostaining, FACS, IP, and ChIP using a unique adjuvant.

Authors:  Philip Sanchez; Karla J Daniels; Yang-Nim Park; David R Soll
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2014-04

Review 5.  TNF-receptor superfamily agonists as molecular adjuvants for cancer vaccines.

Authors:  Timothy Nj Bullock
Journal:  Curr Opin Immunol       Date:  2017-07-24       Impact factor: 7.486

6.  Chemokine Signatures of Pathogen-Specific T Cells I: Effector T Cells.

Authors:  Jens Eberlein; Bennett Davenport; Tom T Nguyen; Francisco Victorino; Kevin Jhun; Verena van der Heide; Maxim Kuleshov; Avi Ma'ayan; Ross Kedl; Dirk Homann
Journal:  J Immunol       Date:  2020-09-18       Impact factor: 5.422

7.  Red blood cell alloimmunization is influenced by the delay between Toll-like receptor agonist injection and transfusion.

Authors:  Rahma Elayeb; Marie Tamagne; Philippe Bierling; France Noizat-Pirenne; Benoît Vingert
Journal:  Haematologica       Date:  2015-10-01       Impact factor: 9.941

8.  Chemokine Signatures of Pathogen-Specific T Cells II: Memory T Cells in Acute and Chronic Infection.

Authors:  Bennett Davenport; Jens Eberlein; Tom T Nguyen; Francisco Victorino; Verena van der Heide; Maxim Kuleshov; Avi Ma'ayan; Ross Kedl; Dirk Homann
Journal:  J Immunol       Date:  2020-09-18       Impact factor: 5.422

9.  IL-6-inducing whole yeast-based immunotherapy directly controls IL-12-dependent CD8 T-cell responses.

Authors:  Beth A Tamburini; Ross M Kedl; Donald Bellgrau
Journal:  J Immunother       Date:  2012-01       Impact factor: 4.456

10.  Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell Responses.

Authors:  Takumi Kumai; Sujin Lee; Hyun-Il Cho; Hussein Sultan; Hiroya Kobayashi; Yasuaki Harabuchi; Esteban Celis
Journal:  Cancer Immunol Res       Date:  2016-12-09       Impact factor: 11.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.